发明授权
US08933086B2 Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors
有权
杂芳基取代的吡咯并[2,3-B]吡啶和吡咯并[2,3-b]嘧啶作为Janus激酶抑制剂
![Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors](/docs/US/2015-01-13/US08933086B2/abs.jpg.600x600.jpg)
- 专利标题： Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors
- 专利标题（中）： 杂芳基取代的吡咯并[2,3-B]吡啶和吡咯并[2,3-b]嘧啶作为Janus激酶抑制剂
-
申请号： US14033039申请日： 2013-09-20
-
公开(公告)号： US08933086B2公开(公告)日： 2015-01-13
- 发明人: James D. Rodgers , Stacey Shepard , Jordan S. Fridman , Krishna Vaddi
- 申请人： Incyte Corporation
- 申请人地址： US DE Wilmington
- 专利权人： Incyte Corporation
- 当前专利权人： Incyte Corporation
- 当前专利权人地址： US DE Wilmington
- 代理机构： Fish & Richardson P.C.
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; A61K31/519 ; A61K45/06 ; C07D471/04 ; A61P35/00
![Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors](/abs-image/US/2015/01/13/US08933086B2/abs.jpg.150x150.jpg)
摘要：
The present invention provides heteroaryl substituted pyrrolo[2,3-b]pyridines and heteroaryl substituted pyrrolo[2,3-b]pyrimidines that modulate the activity of Janus kinases and are useful in the treatment of diseases related to activity of Janus kinases including, for example, immune-related diseases, skin disorders, myeloid proliferative disorders, cancer, and other diseases.
公开/授权文献
信息查询
